Dr. Fleischman on AMDS: A Better Option for High-Risk Type A Dissection Patients
Автор: Artivion, Inc.
Загружено: 2025-10-01
Просмотров: 87
Dr. Fleischman (University of Southern California) cites AMDS potential to prevent many of the complexities (especially arch reoperations) that arise in managing Type A dissections. He stresses that AMDS shows strong performance (mortality, stroke, malperfusion outcomes) in the PERSEVERE and DARTs trials, making him a “full believer.”
Key patient subgroup for AMDS: those with a compressed true lumen and malperfusion—cases where standard hemiarch or even full arch procedures carry higher risk. He notes that AMDS doesn’t greatly complicate reoperation strategy: in limited cases needing re-intervention, AMDS has remained in place and subsequent operations have been feasible. Overall, AMDS is seen by Dr. Fleischman as a superior option for certain high-risk patients, especially those with malperfusion, offering outcomes better than traditional arch or hemiarch surgeries in many settings.
MLENG1754 000
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
